Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Liliemark

Showing results (11-20 of 73) with videos related to

Pageof 8
Sort By:
European Journal of Clinical Pharmacology|January 1, 1993
On the bioavailability of 2-chloro-2'-deoxyadenosine (CdA). The influence of food and omeprazoleF Albertioni, G Juliusson, J Liliemark
Biomedical Chromatography : BMC|November 1, 1991
Determination of 2-chloro-2'-deoxyadenosine in human plasmaJ Liliemark, B Pettersson, G Juliusson
Cancer|August 1, 1995
Disease-related hypocholesterolemia in patients with hairy cell leukemia. Positive correlation with spleen size but not with tumor cell burden or low density lipoprotein receptor activityG Juliusson, S Vitols, J Liliemark
Journal of Chromatography. B, Biomedical Applications|June 28, 1996
Determination of 2-chloro-2'-deoxyadenosine nucleotides in leukemic cells by ion-pair high-performance liquid chromatographyV Reichelova, F Albertioni, J Liliemark
Leukemia Research|January 1, 1992
On the biochemical modulation of 6-mercaptopurine by methotrexate in murine WEHI-3b leukemia cells in vitroJ Liliemark, B Pettersson, C Peterson
Leukemia & Lymphoma|April 1, 1997
Intermittent infusion of cladribine (CdA) in previously treated patients with low-grade non-Hodgkin's lymphomaJ Liliemark, A Porwit, G Juliusson
Blood|June 15, 1994
Flow cytometry of blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells and lymphocyte subsets after treatment with 2-chlorodeoxyadenosineG Juliusson, R Lenkei, J Liliemark
The New England Journal of Medicine|October 8, 1992
Response to 2-chlorodeoxyadenosine in patients with B-cell chronic lymphocytic leukemia resistant to fludarabineG Juliusson, A Elmhorn-Rosenborg, J Liliemark
European Journal of Drug Metabolism and Pharmacokinetics|July 1, 1995
Kinetics and metabolism of 2-chloro-2'-deoxyadenosine and 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine in the isolated perfused rat liverF Albertioni, M Hassan, J Silberring, et al.
European Journal of Clinical Pharmacology|January 1, 1994
Protein binding of 2-chloro 2'-deoxyadenosine (cladribine) in healthy subjects and in patients with leukaemiaF Albertioni, L Herngren, G Juliusson, et al.
Pageof 8

Showing results (11-20 of 73) with videos related to

Sort By:
Pageof 8
European Journal of Clinical Pharmacology|January 1, 1993
On the bioavailability of 2-chloro-2'-deoxyadenosine (CdA). The influence of food and omeprazoleF Albertioni, G Juliusson, J Liliemark
Biomedical Chromatography : BMC|November 1, 1991
Determination of 2-chloro-2'-deoxyadenosine in human plasmaJ Liliemark, B Pettersson, G Juliusson
Cancer|August 1, 1995
Disease-related hypocholesterolemia in patients with hairy cell leukemia. Positive correlation with spleen size but not with tumor cell burden or low density lipoprotein receptor activityG Juliusson, S Vitols, J Liliemark
Journal of Chromatography. B, Biomedical Applications|June 28, 1996
Determination of 2-chloro-2'-deoxyadenosine nucleotides in leukemic cells by ion-pair high-performance liquid chromatographyV Reichelova, F Albertioni, J Liliemark
Leukemia Research|January 1, 1992
On the biochemical modulation of 6-mercaptopurine by methotrexate in murine WEHI-3b leukemia cells in vitroJ Liliemark, B Pettersson, C Peterson
Leukemia & Lymphoma|April 1, 1997
Intermittent infusion of cladribine (CdA) in previously treated patients with low-grade non-Hodgkin's lymphomaJ Liliemark, A Porwit, G Juliusson
Blood|June 15, 1994
Flow cytometry of blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells and lymphocyte subsets after treatment with 2-chlorodeoxyadenosineG Juliusson, R Lenkei, J Liliemark
The New England Journal of Medicine|October 8, 1992
Response to 2-chlorodeoxyadenosine in patients with B-cell chronic lymphocytic leukemia resistant to fludarabineG Juliusson, A Elmhorn-Rosenborg, J Liliemark
European Journal of Drug Metabolism and Pharmacokinetics|July 1, 1995
Kinetics and metabolism of 2-chloro-2'-deoxyadenosine and 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine in the isolated perfused rat liverF Albertioni, M Hassan, J Silberring, et al.
European Journal of Clinical Pharmacology|January 1, 1994
Protein binding of 2-chloro 2'-deoxyadenosine (cladribine) in healthy subjects and in patients with leukaemiaF Albertioni, L Herngren, G Juliusson, et al.
Pageof 8